Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida
- PMID: 16390552
- PMCID: PMC1334214
- DOI: 10.1186/1476-0711-5-1
Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida
Abstract
Background: CHROMagar Candida (CaC) is increasingly being reported as a medium used to differentiate Candida albicans from non-albicans Candida (NAC) species. Rapid identification of NAC can assist the clinician in selecting appropriate antifungal therapy. CaC is a differential chromogenic medium designed to identify C. albicans, C. krusei, and C. tropicalis based on colony color and morphology. Some reports have proposed that CaC can also reliably identify C. dubliniensis and C. glabrata.
Methods: We evaluated the usefulness of CaC in the identification of C. dubliniensis, C. famata, C. firmetaria, C. glabrata, C. guilliermondii, C. inconspicua, C. kefyr, C. lipolytica, C. lusitaniae, C. norvegensis, C. parapsilosis, and C. rugosa.
Results: Most NAC produced colonies that were shades of pink, lavender, or ivory. Several isolates of C. firmetaria and all C. inconspicua produced colonies difficult to differentiate from C. krusei. Most C. rugosa isolates produced unique colonies with morphology like C. krusei except in a light blue-green color. C. glabrata isolates produced small dark violet colonies that could be differentiated from the pink and lavender colors produced by other species. All seventeen isolates of C. dubliniensis produced green colonies similar to those produced by C. albicans.
Conclusion: C. glabrata and C. rugosa appear distinguishable from other species using CaC. Some NAC, including C. firmetaria and C. inconspicua, could be confused with C. krusei using this medium.
Similar articles
-
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.J Hosp Infect. 2002 Apr;50(4):243-60. doi: 10.1053/jhin.2001.1151. J Hosp Infect. 2002. PMID: 12014897 Review.
-
[Comparison of different methods for the identification of Candida species isolated from clinical specimens].Mikrobiyol Bul. 2003 Oct;37(4):269-76. Mikrobiyol Bul. 2003. PMID: 14748264 Turkish.
-
Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity.J Med Microbiol. 2009 Nov;58(Pt 11):1437-1442. doi: 10.1099/jmm.0.011320-0. Epub 2009 Jul 16. J Med Microbiol. 2009. PMID: 19608690
-
Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species.J Clin Microbiol. 2006 Sep;44(9):3340-5. doi: 10.1128/JCM.00213-06. J Clin Microbiol. 2006. PMID: 16954270 Free PMC article.
-
Candida dubliniensis, a new fungal pathogen.J Basic Microbiol. 2002;42(3):207-27. doi: 10.1002/1521-4028(200206)42:3<207::AID-JOBM207>3.0.CO;2-C. J Basic Microbiol. 2002. PMID: 12111748 Review.
Cited by
-
A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.Clin Microbiol Rev. 2017 Apr;30(2):449-479. doi: 10.1128/CMR.00097-16. Clin Microbiol Rev. 2017. PMID: 28122803 Free PMC article. Review.
-
Candida dubliniensis Pneumonia: A Case Report and Review of Literature.Mycopathologia. 2016 Oct;181(9-10):765-8. doi: 10.1007/s11046-016-0032-5. Epub 2016 Jun 24. Mycopathologia. 2016. PMID: 27342836 Review.
-
Simultaneous identification to monitor consortia strain dynamics of four biofuel yeast species during fermentation.J Ind Microbiol Biotechnol. 2020 Dec;47(12):1133-1140. doi: 10.1007/s10295-020-02310-7. Epub 2020 Sep 23. J Ind Microbiol Biotechnol. 2020. PMID: 32965544
-
Uncommon opportunistic fungal infections of oral cavity: A review.J Oral Maxillofac Pathol. 2014 May;18(2):235-43. doi: 10.4103/0973-029X.140765. J Oral Maxillofac Pathol. 2014. PMID: 25328305 Free PMC article. Review.
-
Identification of Candida spp. by phenotypic tests and PCR.Braz J Microbiol. 2010 Apr;41(2):286-94. doi: 10.1590/S1517-83822010000200004. Epub 2010 Jun 1. Braz J Microbiol. 2010. PMID: 24031493 Free PMC article.
References
-
- Trick WE, Fridkin SK, Edwards JR, Hejjeh RA, Gaynes RP, National Nosocomial Infections Surveillance System Hospitals Secular trends of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis. 2002;35:627–630. doi: 10.1086/342300. - DOI - PubMed
-
- Beck-Sague CM, Jarvis WR, NNIS System Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis. 1993;167:1247–1251. - PubMed
-
- Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, Messer SA, SENTRY participant group International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol. 2001;39:3254–3259. doi: 10.1128/JCM.39.9.3254-3259.2001. - DOI - PMC - PubMed
-
- Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M, Pfaller M, Edwards JE, Jarvis W, Dawson J, Wenzel RP, NEMIS Study Group National Epidemiology of Mycoses Survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis. 1999;29:253–258. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources